Skip to main content

Month: August 2022

Mullen Announces Collaboration with Team Rosberg Engineering (TRE) for Vehicle Chassis Development

Founded in 1997 by F1 World Champion Keke Rosberg (‘82) and now led by his son, F1 World Champion Nico Rosberg (‘16), Team Rosberg Engineering (TRE) is working on vehicle chassis and safety development for the Mullen FIVE EV CrossoverTeam Rosberg Engineering supporting Mullen FIVE chassis and safety development Start of production on track for late 2024 and start of 2025.BREA, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today a collaboration with TRE (Team Rosberg Engineering) GmbH from Germany on vehicle chassis and safety development for the Mullen FIVE EV Crossover Program. Mullen is currently working with engineering partner ARRK to finalize the structural layout for the...

Continue reading

HP Unveils New Partner Benefits at Amplify Executive Forum Roadshow

Collaboration, training, engagement, and sustainable impact at the center of HP Amplify program enhancements News Highlights:Enhances HP Amplify Data Insights to deliver action-oriented, customer level insights Expands HP Amplify Impact – industry’s first partner sustainability program – on a global scale Celebrates Partner sustainability efforts with launch of annual Amplify Impact awards Introduces HP Curiocity – new training and partner community engagement platformPALO ALTO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Today at HP Amplify™ Executive Forum, HP Inc’s (NYSE: HPQ) annual partner roadshow, the company unveiled a number of new partner benefits, aimed at driving greater partner collaboration, training opportunities and community engagement. In addition to enhancements to its Amplify Data Insights program, the...

Continue reading

SAVE FOODS ANNOUNCES NOTICE OF PATENT ALLOWANCE IN THE U.S. FOR ITS PROPRIETARY BLEND OF ACIDS BASED TECHNOLOGY TO PROTECT FRUITS AND VEGETABLES FROM DECAY

The patent will strengthen Save Foods’ competitive advantage and expand Save Foods’ protection of the process related to its core technology Neve Yarak, Israel, Aug. 25, 2022 (GLOBE NEWSWIRE) — Save Foods, Inc. (Nasdaq: SVFD) (FSE:80W) (“Save Foods” or the “Company”), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, announced today that the United States Patent and Trademark Office (“USPTO”) has provided the Company a Notice of Allowance for its patent application that relates to a method of protecting food from decay by applying Save Foods blend of food acids. A Notice of Allowance is issued after the USPTO makes the determination that a patent should be granted from an application. The patent is expected to be issued in the...

Continue reading

E-Home Household Services Holdings Limited Awarded RMB 4.7 Million Client Household and Cleaning Service Contracts in August

FUZHOU, China, Aug. 25, 2022 (GLOBE NEWSWIRE) — E-Home Household Service Holdings Limited (Nasdaq: EJH) (the “Company” or “E-Home”), a provider of integrated household services in China, today announced the Company has been awarded household and cleaning service contracts worth a total of RMB 4.7 million in August. Pursuant to the contracts signed, E-Home will be the designated household and cleaning service provider for two years for seven properties under the management of Shanghai Fanying Environment Engineering Co. Ltd., Fujian Company and Fujian Fusheng Property Management Co Ltd. Among the contracts signed, Putian YouYou Cleaning Co., Ltd. (“YouYou”), a subsidiary of the Company, has been awarded RMB2.9 million new property cleaning contracts which last between one and two years to provide daily sweep and maintain cleanliness...

Continue reading

Invesco Ltd.: Form 8.3 – Allied Minds Plc

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Allied Minds plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

With 7.1% CAGR, Plasma Fractionation Market Size worth USD 49.61 Million in 2029

According to Fortune Business Insights, The global plasma fractionation market size was USD 28.69 billion in 2021. The market is projected to grow from USD 30.64 billion in 2022 to USD 49.61 billion by 2029 at a CAGR of 7.1% during the 2022-2029 period. Restricted Plasma Collection Activities Hindered Market Growth Pune, India, Aug. 25, 2022 (GLOBE NEWSWIRE) — The global plasma fractionation market size was USD 28.69 billion in 2021. The market is projected to grow from USD 30.64 billion in 2022 to USD 49.61 billion by 2029 at a CAGR of 7.1% during the 2022-2029 period. Fortune Business Insights™ publishes this information in a report titled, “Plasma Fractionation Market, 2022-2029″. As per the report, the market is projected to grow during the forecast period due to increasing immunodeficiency disorders among population.Get...

Continue reading

TG Therapeutics Announces Results from the ULTIMATE I & II Phase 3 Trials of Investigational Ublituximab in RMS Published in The New England Journal of Medicine

Ublituximab is an investigational targeted B-cell therapy that shows superior efficacy when compared with teriflunomide, a commonly prescribed oral treatment for multiple sclerosis ULTIMATE I and II demonstrated significant reductions in risk of relapses, as well as reduction of active or new brain lesions The US Food and Drug Administration and European Medicines Agency are currently reviewing marketing applications for ublituximab for the treatment of relapsing forms of multiple sclerosis (RMS) in adults If approved, ublituximab will be the first B-cell therapy for use in RMS patients that can be given as a 1- hour infusion every 6 months, following the first dose NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced results from the ULTIMATE I & II Phase 3 trials evaluating ublituximab,...

Continue reading

OpGen Launches Ares Sequencing Services in the U.S. from its Rockville, Maryland Laboratory

Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth opportunity Services at launch include rapid turnaround sequencing of clinical isolates, unique and differentiated interpretative services and the proprietary AREScloud web application for outbreak analysisROCKVILLE, Md., Aug. 25, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that it has launched next generation sequencing (NGS) services in the U.S. that were developed by its subsidiary, Ares Genetics (“Ares”), which strives to become a leader in bacterial genomics and artificial intelligence (AI)-powered antimicrobial resistance (AMR) solutions. The...

Continue reading

Jushi Holdings Inc. to Open Fairfax Dispensary, its 35th Retail Location Nationwide and Fourth Beyond Hello™ Dispensary in Virginia

Jushi Opens Fourth Dispensary in Virginia Jushi Holdings Inc. announced the opening of its fourth medical cannabis dispensary in Virginia and 35th retail location nationwide. Beyond Hello™ Fairfax will begin serving medical cannabis patients and registered agents on Wednesday, August 31st at 10:00 a.m. in-store and through its digital retail experience at beyond-hello.comBeyond Hello™ Fairfax Expands Patient Access in Virginia Located at 10521 Fairfax Blvd. in Fairfax near the corner of Lee Highway and Rt. 123 and just blocks from I-66, Beyond Hello™ Fairfax features 16 traditional and 10 express patient checkouts, along with 45 parking spots with easy in-and-out access to improve patient convenience and accessibility.Virginia Dispensary to Carry Variety of Medical Cannabis Products Beyond Hello™ Fairfax will offer dry leaf,...

Continue reading

SimpleNexus to Power User-Friendly Mobile Homebuying Experience for Approved Mortgage

Locally owned Indiana lender will leverage SimpleNexus’ homeownership platform as a competitive advantage with tech-savvy consumers LEHI, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) — SimpleNexus (https://simplenexus.com/), an nCino (NASDAQ: NCNO) company and developer of the leading U.S. homeownership platform for loan officers, borrowers, real estate agents and settlement agents, today announced that Approved Mortgage has selected SimpleNexus as its point-of-sale (POS) solution. The Indiana-based lender will use SimpleNexus’ mobile-first feature set to enhance its services to clients and real estate professionals while streamlining its internal processes. Thirty years in operation, Approved Mortgage is central Indiana’s oldest and largest locally owned mortgage bank, with over $6.5 billion in loans funded to date. Approved Mortgage...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.